BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 9581779)

  • 1. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines.
    Paxton WA; Liu R; Kang S; Wu L; Gingeras TR; Landau NR; Mackay CR; Koup RA
    Virology; 1998 Apr; 244(1):66-73. PubMed ID: 9581779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
    Paxton WA; Kang S; Koup RA
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S89-92. PubMed ID: 9581891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
    de Roda Husman AM; Blaak H; Brouwer M; Schuitemaker H
    J Immunol; 1999 Oct; 163(8):4597-603. PubMed ID: 10510404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 infectability of CD4+ lymphocytes with relation to beta-chemokines and the CCR5 coreceptor.
    Paxton WA; Kang S; Liu R; Landau NR; Gingeras TR; Wu L; Mackay CR; Koup RA
    Immunol Lett; 1999 Mar; 66(1-3):71-5. PubMed ID: 10203036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CCR5 expression by IL-12 through induction of beta-chemokines in human T lymphocytes.
    Wang J; Guan E; Roderiquez G; Norcross MA
    J Immunol; 1999 Dec; 163(11):5763-9. PubMed ID: 10570258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks.
    Sáez-Cirión A; Versmisse P; Truong LX; Chakrabarti LA; Carpentier W; Barré-Sinoussi F; Scott-Algara D; Pancino G
    Retrovirology; 2006 Nov; 3():81. PubMed ID: 17092330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
    Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of influenza virus vaccine on the expression of human immunodeficiency virus co-receptor CCR5.
    Rucker RP; Day NK; Good RA; Kamchaisatian W; Emmanuel P; Sleasman JW; Mayeski C; Dinglasan E; Haraguchi S; Tangsinmankong N
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):272-6. PubMed ID: 15478388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
    Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
    Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
    Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS
    J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
    Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
    AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progression.
    Paxton WA; Neumann AU; Kang S; Deutch L; Brown RC; Koup RA; Wolinsky SM
    J Infect Dis; 2001 Jun; 183(11):1678-81. PubMed ID: 11343219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone-induced inhibition of chemokine receptor expression on peripheral blood mononuclear cells correlates with reduced HIV-1 infectability in vitro.
    Vassiliadou N; Tucker L; Anderson DJ
    J Immunol; 1999 Jun; 162(12):7510-8. PubMed ID: 10358206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
    Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
    Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
    J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
    Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
    J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms.
    McDyer JF; Dybul M; Goletz TJ; Kinter AL; Thomas EK; Berzofsky JA; Fauci AS; Seder RA
    J Immunol; 1999 Mar; 162(6):3711-7. PubMed ID: 10092834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1 infection of antigen-specific CD4 cytotoxic T lymphocytes.
    Robbins PA; Roderiquez GL; Peden KW; Norcross MA
    AIDS Res Hum Retroviruses; 1998 Nov; 14(16):1397-406. PubMed ID: 9824317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes.
    Patterson BK; Czerniewski M; Andersson J; Sullivan Y; Su F; Jiyamapa D; Burki Z; Landay A
    Clin Immunol; 1999 Jun; 91(3):254-62. PubMed ID: 10370370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.